StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SRDAPRT.BO$88.70+0.00%
Fair $88.70+0.0%

SRDAPRT.BO

Sarda Proteins Ltd

Consumer Defensive / Packaged FoodsBSE

$88.70

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $88.70Fund rank 20/100 · Data gapFallback financials|
SA 33/D
F-Score: 2/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 14%

FCF escenarios

weak_data · normalized FCF $-2.3M · quality 27.7/100

Data gap 20/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 6/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

33/100

D

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 0.2%, below the 5% threshold
Thesis & Journal · SRDAPRT.BOLocal privado en este navegador · Sarda Proteins Ltd
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$153M

P/E

2956.7x

↑

EV/EBITDA

756.2x

↑

ROE

0.2%

↓

Gross Margin

1.2%

↓

Debt/Equity

N/A

•
52-Week Range$89
$60$144

TradingView lightweight chart

SRDAPRT.BO price, volumen y niveles de valoración

Último $88.70Periodo +776.5%
Fair value: $88.70

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+31.0%

FCF CAGR

—

FCF margin

-0.5%

FCF / Net income

-21.69x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $241.9M · net income $51000.0 · FCF $-1.1M

2022-FY → 2025-FY

Gross margin

1.2%-3.2% pts

Operating margin

0.1%-2.4% pts

Net margin

0.0%-2.8% pts

FCF margin

-0.5%-1.4% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$241.9M$241.9M$13.0M$58.0M$107.6M
Net Income$51000.00$51000.00$194000.00$-330290.00$3.1M
EBITDA$202000.00$202000.00$190000.00$129310.00$3.5M
EPS0.030.030.11-0.191.78
Gross Margin1.2%1.2%6.8%1.3%4.4%
Operating Margin0.1%0.1%-11.2%-2.5%2.5%
Net Margin0.0%0.0%1.5%-0.6%2.9%
Balance Sheet
Current Ratio1.031.03———
Cash Flow
Free Cash Flow$-1.1M$-1.1M$-2.3M$-3.0M$1.0M
Returns
ROE0.2%0.2%0.8%-1.4%12.9%
Valuation
P/E2956.672956.67419.73—18.54
EV/EBITDA756.18756.18413.15774.6815.19
P/B6.446.443.364.332.39
Growth & Yield
Revenue Growth1766.9%1766.9%-77.6%-46.1%—
EPS Growth-72.7%-72.7%157.9%-110.7%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

540.2%

muy exigente

EPS terminal req.

$7.87

Spread vs growth

-612.9%

5Y implied EPS CAGR

216.5%

muy exigente

EPS terminal req.

$9.52

Spread vs growth

-289.2%

10Y implied EPS CAGR

86.6%

muy exigente

EPS terminal req.

$15.34

Spread vs growth

-159.3%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -32.3%

Total return

-32.3%

Start / end P/E

1190.5x → 2956.7x

EPS bridge

0.11 → 0.03

Residual

-107.9%

EPS growth-72.7%
Multiple rerating+148.4%
Dividend+0.0%
Residual / FX / buybacks / cross-term-107.9%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.